A narrow indication, not a universal promise
A US FDA 510(k) record for Bioptron Pro/Compact III describes an adjunctive indication for temporary relief of minor chronic neck and shoulder pain. This is specific to the device and indication; it does not establish effectiveness for every kind of pain or every patient.
Pain can have many causes. A clinician should assess new, severe or persistent symptoms and discuss whether a light-therapy session is suitable alongside appropriate care. Avoid changing prescribed treatment on the basis of a device session.
Source consulted: U.S. FDA, device record K032216.
Explore Bioptron Hyperlight Therapy


